1122 Vidutolimod, an immunostimulatory virus-like particle, reduces proliferation but enhances the activation of tumor-specific T cells
Main Authors: | George J Weiner, Caitlin D Lemke-Miltner, Travis D Fischer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Monocytes Exposed to Immune Complexes Reduce pDC Type 1 Interferon Response to Vidutolimod
by: Shakoora A. Sabree, et al.
Published: (2021-09-01) -
1125 In vitro characterization of cellular responses elicited by endosomal TLR agonists encapsulated in Qβ virus-like particles
by: George J Weiner, et al.
Published: (2023-11-01) -
Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates
by: Simon Collett, et al.
Published: (2023-06-01) -
887 In vivo evaluation of the role of T cell help in NK cell mediated ADCC
by: George J Weiner, et al.
Published: (2023-11-01) -
Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade–Resistant Advanced NSCLC
by: Marcelo V. Negrao, MD, et al.
Published: (2023-03-01)